Sinovac Biotech Ltd. (NASDAQ:SVA) shares haven't seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 3 hedge funds' portfolios at the end of the third quarter of 2019. Dakle, američki hedge fondovi drže "kineski" sinovac.